Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug is a way to kill more tumor cells.
PURPOSE: Phase I trial to study the effects of hydroxyurea plus combination chemotherapy in
patients with non-small cell lung cancer.